Comparing rates of clinically relevant epistaxis in patients taking warfarin versus direct oral anticoagulants

Comparing rates of clinically relevant epistaxis in patients taking warfarin versus direct oral anticoagulants

Saved in:

Bibliographic Details
Main Authors:	Khristian S. Burke, Xiaowen Kong, Brian Haymart, Debbie DeCamillo, Mona Ali, Geoff Barnes, Scott Kaatz
Format:	Article
Language:	English
Published:	Elsevier 2024-11-01
Series:	Research and Practice in Thrombosis and Haemostasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S247503792400325X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of Anticoagulation Control among Patients Taking Warfarin in University of Gondar Hospital, Northwest Ethiopia
by: Zelalem Liyew, et al.
Published: (2021-01-01)

New warfarin anticoagulation management model after heart valve surgery: rationale and design of a prospective, multicentre, randomised trial to compare an internet-based warfarin anticoagulation management model with the traditional warfarin management model
by: Yan Li, et al.
Published: (2019-12-01)

Effectiveness and Safety of the Coadministration of Rifampin and Warfarin versus Direct Oral Anticoagulants: A Cohort Study
by: Ju-Chieh Wung, et al.
Published: (2024-01-01)

Mechanism of exacerbation of traumatic brain injury under warfarin anticoagulation in male mice.
by: Yuki Tatara, et al.
Published: (2024-01-01)

Prothrombin Complex Concentrate for Rapid Reversal of Warfarin Anticoagulation to Allow Neuraxial Blockade
by: Conor Skerritt, et al.
Published: (2014-01-01)

Risk of mortality between warfarin and direct oral anticoagulants: population-based cohort studies
by: Zixuan Wang, et al.
Published: (2024-12-01)

Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study
by: Ahmed El-Bardissy, et al.
Published: (2025-01-01)

Approach to Epistaxis
by: Raisa Chowdhury, et al.
Published: (2024-12-01)

The Impact on Efficacy and Safety of Patients Receiving Oral Anticoagulant Medication (Warfarin) during the COVID-19 Pandemic
by: Ubonwan Sapoo, et al.
Published: (2024-07-01)

Pharmacodynamic Modeling of Warfarin Dosing Algorithm for Cardiovascular Patients in Indonesia: A Tailored Method to Anticoagulation Therapy
by: Putriana NA, et al.
Published: (2025-01-01)

Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin in Cirrhotic Patients: A Systematic Review and Meta-Analysis
by: Chunwei Cheng MD, et al.
Published: (2024-11-01)

Comparison of the outcomes of warfarin therapy and economics by online and offline anticoagulation management models: protocol for a randomised controlled trial
by: Xiaotong Xia, et al.
Published: (2019-09-01)

Epistaxis in Adults: Management and Outcome
by: Saif Saeed, et al.
Published: (2024-06-01)

Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
by: Defa Huang, et al.
Published: (2024-12-01)

Epistaxis :Retrospective study of hospitalized patient
by: Habib Alhasani
Published: (2013-01-01)

Management of epistaxis in patients with ventricular assist device: a retrospective review
by: Clifford Scott Brown, et al.
Published: (2018-08-01)

Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis
by: Guan-lian Mo, et al.
Published: (2025-01-01)

Epistaxis first-aid management: a needs assessment among healthcare providers
by: Leigh Sowerby, et al.
Published: (2021-02-01)

Severe Airway Obstruction due to Massive Retropharyngeal Hematoma in a Warfarin-Taking Patient with a Normal International Normalized Ratio
by: Hyun Young Cho, et al.
Published: (2021-03-01)

Examining seasonal variation in epistaxis in a maritime climate
by: Ben McMullin, et al.
Published: (2019-12-01)

Unilateral Tubarial Oncocytic Papillary Cystadenoma Presenting with Epistaxis
by: Nurul Syuhadah Hasny, et al.
Published: (2021-12-01)

Hemorrhagic Lacrimation and Epistaxis in Acute Hemorrhagic Edema of Infancy
by: Shireen Mreish, et al.
Published: (2016-01-01)

Exploring knowledge of first aid in epistaxis—25 years on
by: Henry Dunne, et al.
Published: (2025-01-01)

Frequency and severity of idiopathic epistaxis relative to time of day
by: Juebo Yu, et al.
Published: (2024-12-01)

Endoscopic Sphenopalatine Artery Ligation in Recurrent Epistaxis with Hypertensio
by: Aini Zhann, et al.
Published: (2024-03-01)

Recurrent Massive Epistaxis from an Anomalous Posterior Ethmoid Artery
by: Marco Giuseppe Greco, et al.
Published: (2016-01-01)

Refractory Epistaxis due to Severe Factor V Deficiency with Inhibitor
by: Elizabeth S. John, et al.
Published: (2015-01-01)

Unusual Cause of Persistent Epistaxis with Severe Anemia in a Child
by: Yilkal Zemene, et al.
Published: (2022-01-01)

Systemic Embolism and Clinically Significant Bleeding Events in Older Adults with Nonvalvular Atrial Fibrillation After Treatment with Direct Oral Anticoagulants and Warfarin: A Retrospective Cohort Study in Japan
by: Daichi Yaguchi, et al.
Published: (2024-11-01)

Diffuse Alveolar Hemorrhage Associated with Warfarin Therapy
by: Bülent Kaya, et al.
Published: (2015-01-01)

Warfarin-Associated Diaphragmatic Hernia: An Unusual Diagnosis
by: Cristina Vilhena, et al.
Published: (2015-01-01)

Von-Willebrand Disease Presenting as Intractable Epistaxis after Nasal Polypectomy
by: Jeong Jin Park, et al.
Published: (2014-01-01)

Factors related to the choice of warfarin for treating newly diagnosed nonvalvular atrial fibrillation are associated with safety outcomes during anticoagulation: A new‐user, active‐comparator, retrospective cohort study
by: Yoshiko Takagi, et al.
Published: (2024-12-01)

Informational Competence: A Relevant Conception to Take into Consideration in Higher Education
by: María Elinor Dulzaides Iglesias, et al.
Published: (2007-04-01)

Toxicity for warfarine switching from lopinavir/ritonavir to dolutegravir
by: Ana Pelufo-Pellicer, et al.
Published: (2017-03-01)

Presumptive Haematomyelia Secondary to Warfarin Toxicosis in a Dog
by: Carlos Blanco, et al.
Published: (2022-01-01)

Determining Risk Factors of Bleeding in Patients on Warfarin Treatment
by: Evren Uygungül, et al.
Published: (2014-01-01)

ADVANTAGES AND DISADVANTAGES OF WARFARIN AND PRADAXA THERAPY FOR VENOUS THROMBOEMBOLISM
by: B. S. Sukovatykh, et al.
Published: (2018-01-01)

Risk of development of hemorrhagic complications due to warfarin therapy
by: O. I. Filippova, et al.
Published: (2017-12-01)

Corrigendum to “A Case of Epistaxis as the First Sign of Acute Idiopathic Thrombocytopenic Purpura”
by: Shori Tajima, et al.
Published: (2021-01-01)